sprite-preloader
Anzeige
Mehr »
Donnerstag, 17.08.2017 Börsentäglich über 12.000 News von 559 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiAlvogen to acquire Russia-based Omega Bittner
MiAradigm gets NIH grant for Linhaliq in pulmonary non-tuberculous mycobacteria treatment
MiFDA lifts clinical hold on study of Multikine for head and neck cancer
MiBMS' kidney cancer drug met co-primary endpoint in CheckMate trial
DiH3 Biomedicine gets FDAorphan drug status for acute myelogenous leukemia treatment
DiVicarius Pharma secures $21.8m financing
DiOphthotech's wet-AMD drug Fovista fails in phase 3 AMD trial
MoOxford BioMedica announces collaboration for gene and cell therapy manufacturing
MoPharmaTech liquid drugs recalled in US over bacterial contamination
MoPeregrine Pharmaceuticals cuts 20% of workforce to reduce costs and achieve profitability
FrApellis Pharmaceuticals raises $60m in new funding round
FrGilead gets FDA priority review for bictegravir regimen for HIV treatment
FrSK Capital to acquire Perrigo's Israeli API business
FrCelgene, Sutro revise 2014 immuno-oncology collaboration
10.08.InDex secures FDA orphan-drug designation for cobitolimod
10.08.Heron initiates phase 3 program for HTX-011 in postoperative pain
10.08.Allegro's Luminate succeeds in phase 2 diabetic macular edema trial
10.08.Cancer Research UK, Biotecnol to begin trials of novel immuno-oncology treatment
09.08.Clinigen gets EC nod to update product information for Cardioxane
09.08.Roche agrees to sell eczema drug rights to Dermira
08.08.Genentech gets FDA priority review for Zelboraf in Erdheim-Chester Disease
08.08.Oxford BioMedica secures commercial supply licence from UK MHRA
08.08.Zynerba's cannabis-based epilepsy gel fails in phase 2 trial
07.08.AbbVie's Mavyret secures FDA approval for chronic hepatitis C treatment
07.08.HitGen, LEO Pharma form research collaboration